Neoisoliquiritin, Neoisoliquiritigenin
Kushandiswa kweNeoisoliquiritin
Neoisoliquiritin, yakaparadzaniswa nespatholobus suberectus, yakanyatsobatanidzwa neGRP78 yemitemo β- Catenin nzira inodzivisa kupararira uye inokonzera apoptosis mumasero ekenza yemazamu.
Zita reNeoisoliquiritin
Chirungu Zita :Neoisoliquiritin
Bioactivity yeNeoisoliquiritin
Tsanangudzo: Neoisoliquiritin inoparadzaniswa kubva kune spatholobus suberectus.Neoisoliquiritin yakanyatso kusanganiswa neGRP78 yemutemo β- Catenin nzira inhibisa kuwanda uye inoita kuti apoptosis mumasero ekenza yemazamu.
Zvikamu zvinoenderana: chiratidzo nzira>> apoptosis>> apoptosis
Tsvagiridzo > > gomarara
chinyorwa: [1].TangH, etal.Neoisoliquiritigenin Inhibits Tumor Progression by Targeting GRP78- β- catenin Chiratidzo muCancer Yezamu.Curr Cancer Zvinodhaka Zvinangwa.2018;18(4):390-399.
Physicochemical Properties yeNeoisoliquiritin
Density: 1.528
Boiling Point: 743.5 ± 60.0 ° C pa 760 mmHg
Melting Point: 230-232 ℃
Molecular Formula: c21h22o9
Flash Point: 263.3 ± 26.4 ° C
Hukuru chaihwo: 418.126373
LogP:0.76
Steam Pressure: 0.0 ± 2.6 mmHg pa25 ° C
Refractive Index: 1.707
Chirungu alias yeNeoisoliquiritin
2Y348H1V4W
2-Propen-1-one, 1-(2,4-dihydroxyphenyl)-3-[4-(β-D-glucopyranosyloxy)phenyl]-, (2E)-
Isoliquiritin
MFCD00272145
2-Propen-1-one,1-(2,4-dihydroxyphenyl)-3-(4-(β-D-glucopyranosyloxy)phenyl)-, (2E)-
4-[(1E)-3-(2,4-Dihydroxyphenyl)-3-oxo-1-propen-1-yl]phenyl β-D-glucopyranoside
Iyo kambani Jiangsu Yongjian Pharmaceutical Technology Co., Ltd
Jiangsu Yongjian Pharmaceutical Technology Co., Ltd., yakavambwa muna Kurume 2012, ibhizimusi repamusoro-soro rinobatanidza R & D, kugadzira nekutengesa.Inonyanya kubatanidzwa mukugadzira, kugadzirisa uye kugadzirwa kwemaitiro ekugadzirwa kwezvinhu zvinoshanda zvezvigadzirwa zvechisikigo, zvechinyakare zveChinese mushonga zvinotaridzwa uye kusvibiswa kwezvinodhaka.Iyo kambani iri muChina Pharmaceutical City, Taizhou Guta, Jiangsu Province, inosanganisira 5000 square metre yekugadzira base uye 2000 square metres R & D base.Iyo inonyanya kushanda masangano makuru ekutsvagisa sainzi, mayunivhesiti uye decoction chidimbu mabhizinesi ekugadzira munyika yose.
Parizvino, takagadzira anopfuura zviuru zana nemazana mashanu emhando dzemasikirwo emakemikari reagents, uye akaenzanisa uye calibrated anopfuura mazana matatu marudzi ereferensi ezvinyorwa, izvo zvinogona kuzadzisa zvizere zvinodiwa zvemazuva ese zvekuongorora zvemasangano makuru esainzi, marabhoritari eyunivhesiti uye decoction zvidimbu zvekugadzira mabhizinesi.
Zvichienderana nemusimboti wekutenda kwakanaka, kambani inotarisira kushanda nemoyo wese nevatengi vedu.Chinangwa chedu ndechekushandira kuvandudzwa kwemishonga yechivanhu yechiChinese.
Advantageous Business Scope yeKambani:
1. R & D, kugadzirwa uye kutengesa kwemakemikari ereferensi zvinhu zvechinyakare Chinese mushonga;
2. Customized chinyakare Chinese mushonga monomer compounds maererano mutengi unhu
3. Tsvagiridzo pamusoro pemhando yemhando uye nzira yekuvandudza yechinyakare Chinese mushonga (chirimwa) inotorwa
4. Tekinoroji kubatirana, kutamisa uye kutsvaga zvinodhaka zvitsva nekusimudzira.
